Our data and insights help accelerate innovation and adoption
Life sciences leaders trust our robust real-world data and experienced consultants to connect the dots in ways that answer tough questions, illuminate new possibilities and improve patients’ lives.
Webinar
6 Trends Shaping Pharma Strategies In 2024
A panel of experts from Advisory Board and Optum Life Sciences explains why they believe 2024 is a pivotal year for the entire pharmaceutical value chain.
Solutions for life sciences companies
From data to insight to action, we catalyze clinical innovation
Cutting-edge, enriched data. Unparalleled security and support.
-
Generate evidence with real-world data.
-
Gain greater insights through clinicogenomics.
-
Empower commercial, brand and market access teams.
Expert teams who know how to solve your trickiest problems
-
Strengthen your value story with HEOR.
-
Engage payers with value-based contracts.
-
Partner with our epidemiology consultants.
Narrow the gap between ideas and impact
-
Design, pilot and scale engagement programs.
-
Enhance clinical trial design and performance.
-
Find patients and streamline clinical trials.
Analyst recognition
Optum continues to be a proven leader across a wide range of services and solutions.
Frost & Sullivan
Optum Life Sciences named Company of the Year
IDC MarketScape
Optum positioned as a leader
HFS Horizons
HFS named Optum an 'Enterprise Innovator’ in its 2023 Life Sciences Horizons report.
The 6 trends shaping pharma strategies in 2024
Life sciences market experts from Optum and Advisory Board share perspectives on trends that will influence the future drug value chain.
Latest from Optum Life Sciences
White paper
Clinicogenomics: New data advances life sciences research
The study of clinicogenomics is helping researchers unlock novel insights to guide drug discovery, development and commercialization.
Thought Leadership
Go deeper with innovative life sciences leaders in the industry.
Videos
Learn about forward-thinking strategies from cross-industry experts.
Podcast
Hear how Optum supported the FDA by analyzing COVID-19 vaccine safety.
Cross-industry conversations featuring Optum experts
Inside the science of genetics and genomics by STAT
Explore the evolving research into human genetics and genomics, the promise of gene therapies, and the questions faced in the years ahead.
Inform population-level care with RWD and RWE
Optum and Amgen experts share best practices for using RWD to address questions across the clinical and drug development life cycle.
RWE is critical to the whole health care ecosystem
Lou Brooks, SVP of Real-World Data and Analytics, joins the Radio Advisory podcast to talk about the evolving world of clinical evidence.